Peripheral T-cell lymphoma

Common Name(s)

Peripheral T-cell lymphoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Peripheral T-cell lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Peripheral T-cell lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Peripheral T-cell lymphoma" returned 191 free, full-text research articles on human participants. First 3 results:

NK/T cell lymphoma associated with peripheral eosinophilia.
 

Author(s): E Yap, W F Wan Jamaluddin, N R Tumian, F Mashuri, F Mohammed, G C Tan, N Masir, F S Abdul Wahid

Journal: Malays J Pathol. 2014 Dec;36(3):201-5.

 

NK/T cell lymphoma, nasal type is an aggressive and uncommon malignancy. Disease that occurs outside of the aerodigestive tract exhibits an even more aggressive clinical behaviour and does not respond as well to conventional therapy compared to its nasal counterpart. We report such ...

Last Updated: 16 Dec 2014

Go To URL
[Comparative study on the efficacy of Hyper CVAD/MA regimen and CHOP or CHOP like regimen in the treatment of primary peripheral T cell lymphoma].
 

Author(s): Jin Wang, Lei Gao, Huiying Qiu, Weiping Zhang, Jianmin Yang, Xianmin Song, Shuqing Lyu, Jie Chen, Jianmin Wang

Journal: Zhonghua Xue Ye Xue Za Zhi. 2014 Oct;35(10):897-900.

 

To evaluate the curative efficacy and safety of two regimens, Hyper CVAD/MA and CHOP/CHOP, in the treatment of primary peripheral T cell lymphoma (PTCL).

Last Updated: 23 Oct 2014

Go To URL
Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis.
 

Author(s): J H Schatz, S M Horwitz, J Teruya-Feldstein, M A Lunning, A Viale, K Huberman, N D Socci, N Lailler, A Heguy, I Dolgalev, J C Migliacci, M Pirun, M L Palomba, D M Weinstock, H-G Wendel

Journal: Leukemia. 2015 Jan;29(1):237-41.

 

Last Updated: 8 Jan 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Peripheral T-cell lymphoma" returned 17 free, full-text review articles on human participants. First 3 results:

Therapeutic options in relapsed or refractory peripheral T-cell lymphoma.
 

Author(s): Bertrand Coiffier, Massimo Federico, Dolores Caballero, Claire Dearden, Franck Morschhauser, Ulrich Jäger, Lorenz Trümper, Emanuele Zucca, Maria Gomes da Silva, Ruth Pettengell, Eckhart Weidmann, Francesco d'Amore, Hervé Tilly, Pier Luigi Zinzani

Journal: Cancer Treat. Rev.. 2014 Oct;40(9):1080-8.

 

Peripheral T-cell lymphoma (PTCL) represents a relatively rare group of heterogeneous non-Hodgkin lymphomas with a very poor prognosis. Current therapies, based on historical regimens for aggressive B-cell lymphomas, have resulted in insufficient patient outcomes. The majority of ...

Last Updated: 24 Sep 2014

Go To URL
[Progress of diagnosis and treatment in peripheral T cell lymphoma].
 

Author(s): Ting Liu

Journal: Zhonghua Xue Ye Xue Za Zhi. 2014 Apr;35(4):361-6.

 

Last Updated: 24 Apr 2014

Go To URL
Peripheral T-cell lymphoma: new therapeutic strategies.
 

Author(s): Adam M Petrich, Steven T Rosen

Journal: Oncology (Williston Park, N.Y.). 2013 Sep;27(9):878-84.

 

Between 2006 and 2011, four new agents gained regulatory approval for the treatment of relapsed/refractory cutaneous T-cell lymphoma (CTCL) and peripheral T-cell lymphoma (PTCL). These new approvals, together with recent advances in both combination chemotherapy and transplant strategies, ...

Last Updated: 28 Nov 2013

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma
 

Status: Not yet recruiting

Condition Summary: Relapsed Peripheral T-Cell Lymphoma; Refractory Peripheral T-Cell Lymphoma

 

Last Updated: 4 Jun 2015

Go to URL
Romidepsin in Combination With CHOEP as First Line Treatment Before Hematopoietic Stem Cell Transplantation in Young Patients With Nodal Peripheral T-cell Lymphomas: a Phase I-II Study
 

Status: Recruiting

Condition Summary: Peripheral T-cell Lymphomas (PTCL); Peripheral T-cell Lymphomas Not Otherwise Specified (PTCL-NOS),; Angioimmunoblastic T-cell Lymphoma (AITL); ALK- Anaplastic Largecell Lymphoma (ALCL).

 

Last Updated: 13 Oct 2014

Go to URL
Treatment of Peripheral T-cell Lymphoma
 

Status: Recruiting

Condition Summary: Peripheral T-cell Lymphoma

 

Last Updated: 15 Jul 2015

Go to URL